News
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback